MedTrace Logo

Proton Particle Therapy for Cardiac Arrhythmia

NCT04392193 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2025-01-15

No results posted yet for this study

Summary

Researchers are gathering information on the safety and effectiveness of proton radiation therapy in reducing the number of ventricular tachycardia (VT) episodes in subjects who continue to experience VT despite treatment with an implantable cardioverter defibrillator (ICD) and undergoing a previous catheter ablation.

Conditions

  • Cardiac Arrhythmia

Interventions

RADIATION

Proton Particle Therapy

Proton therapy will be delivered in a single fraction using the Probeat-V system

Sponsors & Collaborators

  • Konstantinos Siontis

    lead OTHER

Principal Investigators

  • Konstantinos Siontis, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-19
Primary Completion
2024-03-09
Completion
2024-03-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04392193 on ClinicalTrials.gov